Pathogenic BRCA2 germline variants in combined hepatocellular‐cholangiocarcinoma

Early View

LETTER TO THE EDITOR

Hongjie Li,

Laboratory Medicine, Geisinger Medical Center, Danville, Pennsylvania, USA

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA

Search for more papers by this authorXuchen Zhang,

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA

Search for more papers by this authorKarin E. Finberg,

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA

Search for more papers by this authorZenta Walther,

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA

Search for more papers by this authorDhanpat Jain,

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA

Search for more papers by this authorJoanna Gibson,

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA

Search for more papers by this author PDFPDF Please review our Terms and Conditions of Use and check box below to share full-text version of article.

I have read and accept the Wiley Online Library Terms and Conditions of Use

Shareable Link

Use the link below to share a full-text version of this article with your friends and colleagues. Learn more.

Share a link

Share on No abstract is available for this article.

Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

留言 (0)

沒有登入
gif